26.03.2013
- Monsanto and DuPont have settled a bitter legal battle over rights to technology for genetically modified seeds and will drop antitrust and patent claims against each other while...
25.03.2013
- Shire is to buy privately owned U.S. biotech firm SARcode Bioscience, paying $160 million upfront to win rights to a new drug in late-stage development for dry eye diseases. The...
25.03.2013
- Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...
22.03.2013
- Monsanto hopes to roll out a new bioengineered, worm-resistant soybean seed for planting in Brazil next season, the firm's local president said, but a successful launch is tied to...
22.03.2013
- European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...
14.03.2013
- Lonza Walkersville and Hyglos, a German biotech company, announced today that they have reached a mutually beneficial global settlement which includes a license agreement for...
08.03.2013
- China has delayed the introduction of genetically-modified rice and corn as it tries to head off public fears, leading government scientists said on Thursday. The world's largest...
07.03.2013
- Purac, a subsidiary of CSM, announces today that it has entered into an agreement to acquire Bird Engineering, the Netherlands. The acquisition will include the intellectual...
